Lipids and lipid‐modifying therapy

Abstract

Dyslipidaemia plays a key role in the development of cardiovascular disease (CVD). Therefore, the identification and treatment of dyslipidaemia is important for both primary and secondary CVD prevention, and forms the basis of this article.